EVMN Evommune, Inc.

NYSE
$9.37

Evommune, Inc. (EVMN) Hedge Fund Activity

This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.

Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.

Hedge fund breadth
+30.43
15 buyers / 8 sellers
STRONG BUYING
Funds compared
26
funds with comparable EVMN positions
22 current holders · 12 prior-quarter holders
Net share change
+1.23M
+3.52M added, -2.29M cut
Position activity
14 new 1 increased 4 reduced 4 exited

Most significant moves

Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.

Fund Action Shares changed Change Est. value Portfolio wt. Score
Vestal Point Capital Growth Healthcare New +1.00M $13.3M 0.3% 64
Perceptive Advisors Growth Healthcare Sold Out -448.4K -100.0% $6.0M 0.0% 63
MARSHALL WACE, LLP Long/Short Sold Out -879.7K -100.0% $11.7M 0.0% 60
Balyasny Asset Management L.P. New +457.0K $6.1M 0.0% 59
OrbiMed Advisors Growth Healthcare New +161.0K $2.1M 0.0% 59
Integral Health Asset Management Growth Healthcare Sold Out -225.0K -100.0% $3.0M 0.0% 59
CITADEL ADVISORS LLC Quant New +10.7K $142.5K 0.0% 58
Holocene Advisors, LP New +111.1K $1.5M 0.0% 58
Point72 Asset Management, L.P. Increased +1.40M +3823.4% $18.6M 0.0% 58
TWO SIGMA INVESTMENTS, LP Quant New +25.5K $339.2K 0.0% 57

Most significant buyers

By move score, not size.

  • Vestal Point Capital New · +1.00M
  • Balyasny Asset Management L.P. New · +457.0K
  • OrbiMed Advisors New · +161.0K
  • CITADEL ADVISORS LLC New · +10.7K
  • Holocene Advisors, LP New · +111.1K

Most significant sellers

By move score, not size.

  • Perceptive Advisors Sold Out · -448.4K
  • MARSHALL WACE, LLP Sold Out · -879.7K
  • Integral Health Asset Management Sold Out · -225.0K
  • Hudson Bay Capital Management Sold Out · -51.4K
  • Verition Fund Management Reduced · -506.1K

Hedge fund positions

Fund Tier Shares Previous Change Change % Portfolio wt. Action Score
Vestal Point Capital 1 1.0M 0 +1.00M 0.3% New 64
Perceptive Advisors 1 0 448.4K -448.4K -100.0% 0.0% Sold Out 63
MARSHALL WACE, LLP 2 0 879.7K -879.7K -100.0% 0.0% Sold Out 60
Balyasny Asset Management L.P. 2 457.0K 0 +457.0K 0.0% New 59
OrbiMed Advisors 2 161.0K 0 +161.0K 0.0% New 59
Integral Health Asset Management 2 0 225.0K -225.0K -100.0% 0.0% Sold Out 59
CITADEL ADVISORS LLC 1 10.7K 0 +10.7K 0.0% New 58
Holocene Advisors, LP 2 111.1K 0 +111.1K 0.0% New 58
Point72 Asset Management, L.P. 1 1.4M 36.6K +1.40M +3823.4% 0.0% Increased 58
TWO SIGMA INVESTMENTS, LP 2 25.5K 0 +25.5K 0.0% New 57
Qube Research & Technologies Ltd 2 30.1K 0 +30.1K 0.0% New 55
LMR Partners 3 118.4K 0 +118.4K 0.0% New 55
Squarepoint Ops LLC 2 47.7K 0 +47.7K 0.0% New 54
Hudson Bay Capital Management 3 0 51.4K -51.4K -100.0% 0.0% Sold Out 53
Quadrature Capital 3 69.3K 0 +69.3K 0.0% New 52
Caption Management 3 30.6K 0 +30.6K 0.0% New 50
Cinctive Capital Management 3 23.6K 0 +23.6K 0.0% New 50
Verition Fund Management 2 43.9K 550.0K -506.1K -92.0% 0.0% Reduced 48
Y-Intercept 4 28.4K 0 +28.4K 0.0% New 48
Quantbot Technologies 4 7.6K 0 +7.6K 0.0% New 45
ExodusPoint Capital Management 3 15.2K 93.9K -78.7K -83.8% 0.0% Reduced 44
ADAR1 Capital Management 3 104.0K 184.1K -80.0K -43.5% 0.1% Reduced 36
Alyeska Investment Group, L.P. 2 704.4K 726.4K -21.9K -3.0% 0.0% Reduced 26
RA Capital Management 1 3.5M 3.5M 0 +0.0% 0.4% Unchanged 29
RTW Investments 1 1.5M 1.5M 0 +0.0% 0.2% Unchanged 27
Baker Bros. Advisors 1 847.4K 847.4K 0 +0.0% 0.1% Unchanged 26

Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Hedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.